Human norovirus as a foodborne pathogen: Challenges and developments

Annual Review of Food Science and Technology

Volumn 6, Issue , 2015, Pages 411-433

  Moore, Matthew D ^a   Goulter, Rebecca M ^a   Jaykus, Lee Ann ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Cell culture; Detection; Epidemiology; Evolution; Infectivity

Indexed keywords

CELL CULTURE; EPIDEMIOLOGY; ERROR DETECTION;

ECONOMIC BURDEN; EVOLUTION; FOOD-BORNE ILLNESS; FOOD-BORNE PATHOGENS; GENETIC STRUCTURE; HUMAN MODEL; INFECTIVITY; NOROVIRUSES;

FOOD MICROBIOLOGY;

ANIMALIA; NOROVIRUS;

ANIMAL; CALICIVIRIDAE INFECTIONS; CELL LINE; CLASSIFICATION; FOOD; GASTROENTERITIS; HUMAN; NOROVIRUS; PATHOGENICITY; PHYLOGENY; VIROLOGY;

ANIMALS; CALICIVIRIDAE INFECTIONS; CELL LINE; FOOD; GASTROENTERITIS; HUMANS; NOROVIRUS; PHYLOGENY;

EID: 84928482095     PISSN: 19411413     EISSN: 19411421     Source Type: Journal    
DOI: 10.1146/annurev-food-022814-015643     Document Type: Review

References (153)

1. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, et al. 2013. Determination of the human infectious dose-50% for Norwalk virus. J. Infect. Dis. 209(7):1016-22
2. Bae J, Schwab KJ. 2008. Evaluation of murine norovirus, feline calicivirus, poliovirus, and MS2 as surrogates for human norovirus in a model of viral persistence in surface water and groundwater. Appl. Environ. Microbiol. 74(2):477-84
3. Baert L, Debevere J, Uyttendaele M. 2009a. The efficacy of preservation methods to inactivate foodborne viruses. Int. J. Food Microbiol. 131:83-94
4. Baert L, Uyttendaele M, Stals A, Van Coillie E, Dierick K, et al. 2009b. Reported foodborne outbreaks due to noroviruses in Belgium: the link between food and patient investigations in an international context. Epidemiol. Infect. 137(3):316-25
5. Batz MB, Hoffmann S, Morris JG. 2012. Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J. Food Prot. 75(7):1278-91
6. Belliot G, Sosnovtsev SV, Chang K-O, McPhie P, Green KY. 2008. Nucleotidylylation of the VPg protein of a human norovirus by its proteinase-polymerase precursor protein. Virology 374(1):33-49
7. Blakeney SJ, Cahill A, Reilly PA. 2003. Processing of Norwalk virus nonstructural proteins by a 3C-like cysteine proteinase. Virology 308(2):216-24
8. Bok K, Parra GI, Mitra T, Abente E, Shaver CK, et al. 2011. Chimpanzees as an animal model for human norovirus infection and vaccine development. PNAS 108(1):325-30
9. Bosch A, Guix S, Sano D, Pint'o RM. 2008. New tools for the study and direct surveillance of viral pathogens in water. Curr. Opin. Biotechnol. 19(3):295-301
10. Boxman ILA, Verhoef L, Dijkman R, Hagele G, te Loeke NAJM, Koopmans M. 2011. Year-round prevalence of norovirus in the environment of catering companies without a recently reported outbreak of gastroenteritis. Appl. Environ. Microbiol. 77(9):2968-74
11. Bull RA, Eden J-S, Luciani F, McElroy K, Rawlinson WD, White PA. 2012. Contribution of intra-and interhost dynamics to norovirus evolution. J. Virol. 86(6):3219-29
12. Bull RA, Eden J-S, Rawlinson WD, White PA. 2010. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLOS Pathog. 6(3):e10008
13. Bull RA,Hansman GS, Clancy LE, Tanaka MM, RawlinsonWD, White PA. 2005. Norovirus recombination in orf1/orf2 overlap. Emerg. Infect. Dis. 11(7):1079-85
14. Butot S, Zuber S, Baert L. 2014. Sample preparation prior to molecular amplification: complexities and opportunities. Curr. Opin. Virol. 4:66-70
15. Cannon JL, Papafragkou E, Park GW, Osborne J, Jaykus L-A, Vinj'e J. 2006. Surrogates for the study of norovirus stability and inactivation in the environment: a comparison of murine norovirus and feline calicivirus. J. Food Prot. 69(11):2761-65
16. Ceuppens S, Li D, Uyttendaele M, Renault P, Ross P, et al. 2014. Molecular methods in food safety microbiology: interpretation and implications of nucleic acid detection. Compr. Rev. Food Sci. Food Saf. 13(4):551-77
17. Cheetham S, SouzaM,McGregor R, Meulia T, Wang Q, Saif LJ. 2007. Binding patterns of human noroviruslike particles to buccal and intestinal tissues of gnotobiotic pigs in relation to A/H histo-blood group antigen expression. J. Virol. 81(7):3535-44
18. Cheetham S, Souza M, Meulia T, Grimes S, Han MG, Saif LJ. 2006. Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J. Virol. 80(21):10372-81
19. Dancho BA, Chen H, Kingsley DH. 2012. Discrimination between infectious and non-infectious human norovirus using porcine gastric mucin. Int. J. Food Microbiol. 155(3):222-26
20. Daughenbaugh KF, Fraser CS, Hershey JWB, Hardy ME. 2003. The genome-linked protein VPg of the Norwalk virus binds eIF3, suggesting its role in translation initiation complex recruitment. EMBO J. 22(11):2852-59
21. de Abreu Correa A, Carratala A, Barardi CRM, Calvo M, Girones R, Bofill-Mas S. 2012. Comparative inactivation ofmurine norovirus, human adenovirus, and human JCpolyomavirus by chlorine in seawater. Appl. Environ. Microbiol. 78(18):6450-57
22. Debbink K, Donaldson EF, Lindesmith LC, Baric RS. 2012. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J. Virol. 86(2):1214-26
23. Debbink K, Lindesmith LC, Donaldson EF, Costantini V, Beltramello M, et al. 2013. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J. Infect. Dis. 208(11):1877-87
24. DePaola A, Jones JL, Woods J, Burkhardt W, Calci KR, et al. 2010. Bacterial and viral pathogens in live oysters: 2007 United States market survey. Appl. Environ. Microbiol. 76(9):2754-68
25. Diez-Valcarce M, KovacK, Raspor P, Rodr'guez-L'azaroD,Hern'andezM. 2011. Virus genome quantification does not predict norovirus infectivity after application of food inactivation processing technologies. Food Environ. Virol. 3(3-4):141-46
26. Dolin R, Blacklow NR, DuPont H, Buscho RF, Wyatt RG, et al. 1972. Biological properties ofNorwalk agent of acute infectious nonbacterial gastroenteritis. Exp. Biol. Med. 140(2):578-83
27. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS. 2008. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol. Rev. 225:190-211
28. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS. 2010. Viral shape-shifting: norovirus evasion of the human immune system. Nat. Rev. Microbiol. 8(3):231-41
29. Doultree JC, Druce JD, Birch CJ, Bowden DS,Marshall JA. 1999. Inactivation of feline calicivirus, a Norwalk virus surrogate. J. Hosp. Infect. 41(1):51-57
30. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK. 2004. Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 85(1):79-87
31. Eden J-S, Tanaka MM, Boni MF, Rawlinson WD, White PA. 2013. Recombination within the pandemic norovirus GII.4 lineage. J. Virol. 87(11):6270-82
32. Escudero-Abarca BI, Rawsthorne H, Goulter RM, Suh SH, Jaykus L-A. 2014. Molecular methods used to estimate thermal inactivation of a prototype human norovirus: more heat resistant than previously believed Food Microbiol. 41:91-95
33. Farkas T, Cross RW, Hargitt E, Lerche NW, Morrow AL, Sestak K. 2010. Genetic diversity and histo-blood group antigen interactions of rhesus enteric caliciviruses. J. Virol. 84(17):8617-25
34. Farkas T, Sestak K, Wei C, Jiang X. 2008. Characterization of a rhesus monkey calicivirus representing a new genus of caliciviridae. J. Virol. 82(11):5408-16
35. Flynn WT, Saif LJ. 1988. Serial propagation of porcine enteric calicivirus-like virus in primary porcine kidney cell cultures. J. Clin. Microbiol. 26(2):206-12
36. Fukushi S, Kojima S, Takai R, Hoshino FB, Oka T, et al. 2004. Poly (A)-and primer-independent RNA polymerase of norovirus. J. Virol. 78(8):3889-96
37. Giammanco GM, Rotolo V, Medici MC, Tummolo F, Bonura F, et al. 2012. Recombinant norovirus GII.g/GII.12 gastroenteritis in children. Infect. Genet. Evol. 12(1):169-74
38. Gilling DH, Kitajima M, Torrey JR, Bright KR. 2014. Antiviral efficacy and mechanisms of action of oregano essential oil and its primary component carvacrol against murine norovirus. J. Appl.Microbiol. 116(5):1149-63
39. Glass PJ, White LJ, Ball JM, Leparc-Goffart I, Hardy ME, Estes MK. 2000. Norwalk virus open reading frame 3 encodes a minor structural protein. J. Virol. 74(14):6581-91
40. Glass RI, Parashar UD, Estes MK. 2009. Norovirus gastroenteritis. N. Engl. J. Med. 361(1):1776-85
41. Goodfellow I, Chaudhry Y, Gioldasi I, Gerondopoulos A, Natoni A, et al. 2005. Calicivirus translation initiation requires an interaction between VPg and eIF4E. EMBO Rep. 6(10):968-72
42. Gould LH, Walsh KA, Vieira AR, Herman K, Williams IT, et al. 2013. Surveillance for foodborne disease outbreaks-United States, 1998-2008. MMWR Surveill. Summ. 62(SS2):1-34
43. Greig JD, Ravel A. 2009. Analysis of foodborne outbreak data reported internationally for source attribution. Int. J. Food Microbiol. 130(2):77-87
44. Guix S, Asanaka M, Katayama K, Crawford SE, Neill FH, et al. 2007. Norwalk virus RNA is infectious in mammalian cells. J. Virol. 81(22):12238-48
45. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. 2012a. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin. Infect. Dis. 55(2):216-23
46. Hall AJ, EisenbartVG, Eting ue AL,GouldLH, Lopman BA,ParasharUD.2012b. Epidemiology of foodborne norovirus outbreaks, United States, 2001-2008. Emerg. Infect. Dis. 18(10):2001-8
47. Hall AJ, Lopman BA, Payne DC, Patel MM, Gasta ñaduy PA, et al. 2013. Norovirus disease in the United States. Emerg. Infect. Dis. 19(8):1198-205
48. Hall AJ, Wikswo ME, Pringle K, Gould LH, Parashar UD. 2014. Vital signs: foodborne norovirus outbreaks-United States, 2009-2012. MMWR 63(22):491-95
49. Herbst-Kralovetz MM, Radtke AL, Lay MK, Hjelm BE, Bolick AN, et al. 2013. Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg. Infect. Dis. 19(3):431-38
50. Hirneisen KA, Black EP, Cascarino JL, Fino VR, Hoover DG, Kniel KE. 2010. Viral inactivation in foods: a review of traditional and novel food-processing technologies. Compr. Rev. Food Sci. Food Saf. 9(1):3-20
51. Hirneisen KA, Kniel KE. 2013a. Comparing human norovirus surrogates: murine norovirus and Tulane virus. J. Food Prot. 76(1):139-43
52. Hirneisen KA, Kniel KE. 2013b. Norovirus surrogate survival on spinach during preharvest growth. Phytopathology 103(4):389-94
53. Hoelzer K, Fanaselle W, Pouillot R, Van Doren JM, Dennis S. 2013. Virus inactivation on hard surfaces or in suspension by chemical disinfectants: systematic review and meta-analysis of norovirus surrogates. J. Food Prot. 76(6):1006-16
54. Hoorfar J,Malorny B, Abdulmawjood A, Cook N, Fach P, Wagner M. 2004. Practical considerations in design of internal amplification controls for diagnostic PCR assays. J. Clin. Microbiol. 45(5):1863-68
55. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clouet N, et al. 2003. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis. 188(1):19-31
56. Huang P, Farkas T, Zhong W, Tan M, Thornton S, et al. 2005. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 79(11):6714-22
57. International Organization for Standardization (ISO). 2013. ISO/TS 15216-1, 2: 2013 Microbiology of food and animal feed-Horizontal method for determination of hepatitis A virus and norovirus in food using real-time RT-PCR-Part 1:Method for quantification, Part 2: Method for qualitative detection.Geneva, Switzerland
58. Jiang B, McClure HM, Fankhauser RL, Monroe SS, Glass RI. 2004. Prevalence of rotavirus and norovirus antibodies in non-human primates. J. Med. Primatol. 33(1):30-33
59. Jiang X,Wang M, Graham DY, Estes MK. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66(11):6527-32
60. Jiang X,Wang M,Wang K, Estes MK. 1993. Sequence and genomic organization of Norwalk virus. Virology 195:51-61
61. Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR, et al. 2014. Enteric bacteria promote human and mouse norovirus infection of B cells. Science 346(6210):755-59
62. Kahan SM, Liu G, Reinhard MK, Hsu CC, Livingston RS, Karst SM. 2011. Comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology. Virology 421(2):202-10
63. Karst SM, Wobus CE, Goodfellow IG, Green KY, Virgin HW. 2014. Advances in norovirus biology. Cell Host Microbe. 15(6):668-80
64. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW. 2003. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299(5612):1575-78
65. Kim SY, Ko G. 2012. Using propidium monoazide to distinguish between viable and nonviable bacteria, MS2 and murine norovirus. Lett. Appl. Microbiol. 55(3):182-88
66. Knight A, Li D, UyttendaeleM,Jaykus L-A. 2013.Acritical review of methods for detecting human noroviruses and predicting their infectivity. Crit. Rev. Microbiol. 39(3):295-309
67. Kostela J, Ayers M, Nishikawa J, McIntyre L, Petric M, Tellier R. 2008. Amplification by long RT-PCR of near full-length norovirus genomes. J. Virol. Methods 149(2):226-30
68. Kovbasnjuk O, Zachos NC, In J, Foulke-Abel J, Ettayebi K, et al. 2013. Human enteroids: preclinical models of non-inflammatory diarrhea. Stem Cell Res. Ther. 4(Suppl. 1):S3
69. Kroneman A, Vega E, Vennema H, Vinj'e J,White PA, et al. 2013. Proposal for a unified norovirus nomenclature and genotyping. Arch. Virol. 158(10):2059-68
70. Lambden PR, Caul EO, Ashley CR, Clarke IN. 1993. Sequence and genome organization of a human small round-structured (Norwalk-like) virus. Science 259(5094):516-19
71. Lamhoujeb S, Fliss I, Ngazoa SE, Jean J. 2008. Evaluation of the persistence of infectious human noroviruses on food surfaces by using real-time nucleic acid sequence-based amplification. Appl. Environ. Microbiol. 74(11):3349-55
72. Lay MK, Atmar RL, Guix S, Bharadwaj U, He H, et al. 2010. Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology 406(1):1-11
73. Leon JS, Kingsley DH, Montes JS, Richards GP, Lyon GM, et al. 2011. Randomized, double-blinded clinical trial for human norovirus inactivation in oysters by high hydrostatic pressure processing. Appl. Environ. Microbiol. 77(15):5476-82
74. LeungWK, Chan PKS, Lee NLS, Sung JJY. 2010. Development of an in vitro cell culture model for human noroviruses and its clinical application. Hong Kong Med. J. 16(Suppl. 4):S18-21
75. Li D, Baert L, Van Coillie E, Uyttendaele M. 2011. Critical studies on binding-based RT-PCR detection of infectious noroviruses. J. Virol. Methods 177(2):153-59
76. Li D, Baert L, Xia M, Zhong W, Van Coillie E, et al. 2012a. Evaluation of methods measuring the capsid integrity and/or functions of noroviruses by heat inactivation. J. Virol. Methods 181(1):1-5
77. Li J, Predmore A, Divers E, Lou F. 2012b. New interventions against human norovirus: progress, opportunities, and challenges. Annu. Rev. Food Sci. Technol. 3:331-52
78. Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, et al. 2012. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLOS Pathog. 8(5):e10027
79. Lindesmith LC, Costantini V, Swanstrom J, Debbink K, Donaldson EF, et al. 2013. Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J. Virol. 87(5):2803-13
80. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng D-P, et al. 2008. Mechanisms of GII.4 norovirus persistence in human populations. PLOS Med. 5(2):e31
81. Lindesmith LC, Moe C, Lependu J, Frelinger A, Treanor J, Baric RS. 2005. Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 79(5):2900-9
82. Liu B, Clarke IN, Lambden PR. 1996. Polyprotein processing in Southampton virus: identification of 3C-like protease cleavage sites by in vitro mutagenesis. J. Virol. 70(4):2605-10
83. Liu P, Escudero B, Jaykus L-A, Montes J, Goulter RM, et al. 2013. Laboratory evidence of Norwalk virus contamination on the hands of infected individuals. Appl. Environ. Microbiol. 79(24):7875-81
84. Loisy F, Atmar RL, Guillon P, Le Cann P, Pommepuy M, Le Guyader FS. 2005. Real-time RT-PCR for norovirus screening in shellfish. J. Virol. Methods 123(1):1-7
85. Martella V, Lorusso E, Decaro N, Elia G, Radogna A, et al. 2008. Detection and molecular characterization of a canine norovirus. Emerg. Infect. Dis. 14(8):1306-8
86. Matthews JE, Dickey BW, Miller RD, Felzer JR, Dawson BP, et al. 2012. The epidemiology of published norovirus outbreaks: a review of risk factors associated with attack rate and genogroup. Epidemiol. Infect. 140(7):1161-72
87. Mattison K, Harlow J, Vanessa M, Cook A, Pollari F, et al. 2010. Enteric viruses in ready-to-eat packaged leafy greens. Clin. Infect. Dis. 16(11):1815-16
88. Maurer JJ. 2011. Rapid detection and limitations of molecular techniques. Annu. Rev. Food Sci. Technol. 2:259-79
89. Meyers G, Wirblich C, Thiel HJ. 1991. Rabbit hemorrhagic disease virus-molecular cloning and nucleotide sequencing of a calicivirus genome. Virology 184(2):664-76
90. Murakami K, Kurihara C, Oka T, Shimoike T, Fujii Y, et al. 2013. Norovirus binding to intestinal epithelial cells is independent of histo-blood group antigens. PLOS ONE 8(6):e66534
91. Nowak P, Topping JR, Bellamy K, Fotheringham V, Gray JJ, et al. 2011a. Virolysis of feline calicivirus and human GII.4 norovirus following chlorine exposure under standardized light soil disinfection conditions. J. Food Prot. 74(12):2113-18
92. Nowak P, Topping JR, Fotheringham V, Gallimore CI, Gray JJ, et al. 2011b. Measurement of the virolysis of human GII.4 norovirus in response to disinfectants and sanitisers. J. Virol. Methods 174(1-2):7-11
93. Nuanualsuwan S, Cliver DO. 2002. Pretreatment to avoid positive RT-PCR results with inactivated viruses. J. Virol. Methods 104(2):217-25
94. Painter JA, Hoekstra RM, Ayers T, Tauxe RV, Braden CR, et al. 2013. Attribution of foodborne illnesses, hospitalizations, and deaths to food commodities by using outbreak data, United States, 1998-2008. Emerg. Infect. Dis. 19(3):407-15
95. Papafragkou E, Hewitt J, Park GW, Greening G, Vinj'e J. 2013. Challenges of culturing human norovirus in three-dimensional organoid intestinal cell culture models. PLOS ONE 8(6):e63485
96. Park GW, Barclay L, Macinga D, Charbonneau D, Pettigrew CA, Vinj'e J. 2010. Comparative efficacy of seven hand sanitizers against murine norovirus, feline calicivirus, and GII.4 norovirus. J. Food Prot. 73(12):2232-38
97. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. 1977. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med. 297(2):86-89
98. Parshionikar S, Laseke I, Fout GS. 2010. Use of propidium monoazide in reverse transcriptase PCR to distinguish between infectious and noninfectious enteric viruses in water samples. Appl. Environ.Microbiol. 76(13):4318-26
99. Patel MM, WiddowsonM-A, Glass RI, Akazawa K, Vinj'e J, Parashar UD. 2008. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis. 14(8):1224-31
100. Pecson BM, Ackermann M, Kohn T. 2011. Framework for using quantitative PCR as a nonculture based method to estimate virus infectivity. Environ. Sci. Technol. 45(6):2257-63
101. Pecson BM, Martin LV, Kohn T. 2009. Quantitative PCR for determining the infectivity of bacteriophage MS2 upon inactivation by heat, UV-B radiation, and singlet oxygen: advantages and limitations of an enzymatic treatment to reduce false-positive results. Appl. Environ. Microbiol. 75(17):5544-54
102. Pfister T, Wimmer E. 2001. Polypeptide p41 of aNorwalk-like virus is a nucleic acid-independent nucleoside triphosphatase. J. Virol. 75(4):1611-19
103. Phillips G, Tam CC, Conti S, Rodrigues LC, Brown D, et al. 2010. Community incidence of norovirusassociated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. Am. J. Epidemiol. 171(9):1014-22
104. Prasad BVV, HardyME, Dokland T, Bella J, RossmanMG, EstesMK. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science 286(5438):287-90
105. Rha B, Burrer S, Park S, Trivedi T, Parashar UD, Lopman BA. 2013. Emergency department visit data for rapid detection and monitoring of norovirus activity, United States. Emerg. Infect. Dis. 19(8):1214-21
106. Richards GP. 1999. Limitations ofmolecular biological techniques for assessing the virological safety of foods. J. Food Prot. 62(6):691-97
107. Richards GP. 2012. Critical review of norovirus surrogates in food safety research: rationale for considering volunteer studies. Food Environ. Virol. 4(1):6-13
108. Rockx BHG, Bogers WMJM,Heeney JL, van Amerongen G, KoopmansMPG. 2005. Experimental norovirus infections in non-human primates. J. Med. Virol. 75(2):313-20
109. Rohayem J, Mu J, Rethwilm A. 2005. Evidence of recombination in the norovirus capsid gene. J. Virol. 79(8):4977-90
110. Rohayem J, Robel I, Jäger K, Scheffler U, Rudolph W. 2006. Protein-primed and de novo initiation of RNA synthesis by norovirus 3Dpol. J. Virol. 80(14):7060-69
111. Rutjes SA, Lodder-Verschoor F, Maria ANA, Husman R. 2006. Detection of noroviruses in foods: a study on virus extraction. J. Food Prot. 69(8):1949-56
112. Sánchez G, Elizaqúvel P, Aznar R. 2012. Discrimination of infectious hepatitis A viruses by propidium monoazide real-time RT-PCR. Food Environ. Virol. 4(1):21-25
113. Sano D, Pintó RM, Omura T, Bosch A. 2010. Detection of oxidative damages on viral capsid protein for evaluating structural integrity and infectivity of human norovirus. Environ. Sci. Technol. 44(2):808-12
114. Scallan E, Griffin PM, Angulo FJ, Tauxe RV, Hoekstra RM. 2011a. Foodborne illness acquired in the United States-unspecified agents. Emerg. Infect. Dis. 17(1):16-22
115. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, et al. 2011b. Foodborne illness acquired in the United States-major pathogens. Emerg. Infect. Dis. 17(1):7-15
116. Schrader C, Schielke A, Ellerbroek L, Johne R. 2012. PCR inhibitors-occurrence, properties and removal. J. Appl. Microbiol. 113(5):1014-26
117. Seitz SR, Leon JS, SchwabKJ, LyonGM,DowdM, et al. 2011. Norovirus infectivity in humans and persistence in water. Appl. Environ. Microbiol. 77(19):6884-88
118. Shin G, Sobsey MD. 2003. Reduction of Norwalk virus, poliovirus 1, and bacteriophage MS2 by ozone disinfection of water. Appl. Environ. Microbiol. 69(7):3975-78
119. Siebenga JJ, Beersma MFC, Vennema H, van Biezen P, Hartwig NJ, Koopmans M. 2008. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J. Infect. Dis. 198(7):994-1001
120. SouzaM, AzevedoMSP, Jung K, Cheetham S, Saif LJ. 2008. Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus. J. Virol. 82(4):1777-86
121. Stals A, Baert L, Van Coillie E, Uyttendaele M. 2011. Evaluation of a norovirus detection methodology for soft red fruits. Food Microbiol. 28(1):52-58
122. Straub TM, Bartholomew RA, Valdez CO, Valentine NB, Dohnalkova A, et al. 2011. Human norovirus infection of Caco-2 cells grown as a three-dimensional tissue structure. J. Water Health 9(2):225-40
123. Straub TM, Höner zu Bentrup K, Orosz-Coghlan P, Dohnalkova A, Mayer BK, et al. 2007. In vitro cell culture infectivity assay for human noroviruses. Emerg. Infect. Dis. 13(3):396-403
124. Subba-Reddy CV, Goodfellow I, Kao CC. 2011. VPg-primed RNA synthesis of norovirus RNA-dependent RNA polymerases by using a novel cell-based assay. J. Virol. 85(24):13027-37
125. Sukhrie FHA,BeersmaMFC,WongA, van der Veer B, Vennema H, et al. 2011. Using molecular epidemiology to trace transmission of nosocomial norovirus infection. J. Clin. Microbiol. 49(2):602-6
126. Swanstrom J, Lindesmith LC,Donaldson EF, Yount B, Baric RS. 2014. Characterization of blockade antibody responses in GII.2.1976 SMV infected subjects. J. Virol. 88(2):829-37
127. Takanashi S, Saif LJ, Hughes JH, Meulia T, Jung K, et al. 2014. Failure of propagation of human norovirus in intestinal epithelial cells with microvilli grown in three-dimensional cultures. Arch. Virol. 159(2):257-66
128. Takanashi S, Wang Q, Chen N, Shen Q, Jung K, et al. 2011. Characterization of emerging GII.g/GII.12
129. noroviruses from a gastroenteritis outbreak in the United States in 2010. J. Clin. Microbiol. 49(9):3234-44
130. Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, et al. 2012. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 61(1):69-77
131. Tang Q, Li D, Xu J, Wang J, Zhao Y, et al. 2010. Mechanism of inactivation of murine norovirus-1 by high pressure processing. Int. J. Food Microbiol. 137(2-3):186-89
132. Taube S, Kolawole AO, Höhne M, Wilkinson JE, Handley SA, Perry JW. 2013. A mouse model for human norovirus. mBio 4(4):e00450
133. Teunis PFM, Moe CL, Liu P, Miller SE, Lindesmith L, et al. 2008. Norwalk virus: how infectious is it J. Med. Virol. 80:1468-76
134. Thomas MK, Murray R, Flockhart L, Pintar K, Pollari F, et al. 2013. Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006. Foodborne Pathog. Dis. 10(7):639-48
135. Thorne LG, Goodfellow IG. 2014. Norovirus gene expression and replication. J. Gen. Virol. 95:278-91
136. Topping JR, Schnerr H, Haines J, Scott M, Carter MJ, et al. 2009. Temperature inactivation of feline calicivirus vaccine strain FCV F-9 in comparison with human noroviruses using an RNA exposure assay and reverse transcribed quantitative real-time polymerase chain reaction-a novel method for predicting virus infectivity. J. Virol. Methods 156:89-95
137. TseH, Lau SKP, Chan W-M, Choi GKY, Woo PCY, Yuen K-Y. 2012. Complete genome sequences of novel canine noroviruses in Hong Kong. J. Virol. 86(17):9531-32
138. Tung G, Macinga D, Arbogast J, Jaykus L-A. 2013. Efficacy of commonly used disinfectants for inactivation of human noroviruses and their surrogates. J. Food Prot. 76(7):1210-17
139. van Beek J, Ambert-Balay K, Botteldoorn N, Eden JS, Fonager J, et al. 2013. Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveill. 18(1):8-9
140. van den Berg H, LodderW, van der PoelW, Vennema H, de Roda Husman AM. 2005. Genetic diversity of noroviruses in raw and treated sewage water. Res. Microbiol. 156(4):532-40
141. Vashist S, Bailey D, Putics A, Goodfellow I. 2009. Model systems for the study of human norovirus biology. Future Virol. 4(4):353-67
142. Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinjé J. 2014. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009-2013. J. Clin. Microbiol. 52(1):147-55
143. Vega E, Barclay L, GregoricusN,Williams K, Lee D, Vinjé J. 2011. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg. Infect. Dis. 17(8):1389-95
144. Verhoef L, Kouyos RD, Vennema H, Kroneman A, Siebenga J, et al. 2011. An integrated approach to identifying international foodborne norovirus outbreaks. Emerg. Infect. Dis. 17(3):412-18
145. Verhoef L, Vennema H, van PeltW, Lees D, Boshuizen H, et al. 2010. Use of norovirus genotype profiles to differentiate origins of foodborne outbreaks. Emerg. Infect. Dis. 16(4):617-24
146. Verhoef L, Williams KP, Kroneman A, Sobral B, van Pelt W, Koopmans M. 2012. Selection of a phylogenetically informative region of the norovirus genome for outbreak linkage. Virus Genes 44(1):8-18
147. Vinjé J. 2015. Advances in laboratory methods for detection and typing of norovirus. J. Clin. Microbiol. 53(2):373-81
148. Wang Q, Hirneisen KA, Markland SM, Kniel KE. 2013. Survival of murine norovirus, Tulane virus, and hepatitis A virus on alfalfa seeds and sprouts during storage and germination. Appl. Environ. Microbiol. 79(22):7021-27
149. Waters A, Coughlan S, Hall WW. 2007. Characterisation of a novel recombination event in the norovirus polymerase gene. Virology 363(1):11-14
150. White PA. 2014. Evolution of norovirus. Clin. Microbiol. Infect. 20(8):741-45
151. Wobus CE, Thackray LB, Virgin HW. 2006. Murine norovirus: a model system to study norovirus biology and pathogenesis. J. Virol. 80(11):5104-12
152. Wolf S, Rivera-Aban M, Greening GE. 2009. Long-range reverse transcription as a useful tool to assess the genomic integrity of norovirus. Food Environ. Virol. 1(3-4):129-36
153. Zheng D-P, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. 2006. Norovirus classification and proposed strain nomenclature. Virology 346(2):312-23